Background: Inhaled corticosteroids are used increasingly to treat people with COPD, but
the extent to which these drugs increase the risk of fracture is unclear. Aim: To quantify the …

Patients with chronic obstructive pulmonary disease (COPD) are frequently treated with
inhaled corticosteroids (ICS). However, the impact of ICS use on fracture risk remains …

Background The effect of inhaled corticosteroids (ICS) on fracture risk in patients with
chronic obstructive pulmonary disease (COPD) remains uncertain. The aim of this study was …

Studies of the risk of fracture associated with inhaled corticosteroids are inconclusive and
are limited to short-term effects. We assessed whether long-term use increases this risk. We …

Background The fracture risk of patients with chronic obstructive pulmonary disease (COPD)
treated with inhaled corticosteroids is controversial. And some large-scale randomized …

Background Previous studies have found an association between the use of inhaled
corticosteroids and fracture, but the extent to which this association is due to inhaled …

The use of inhaled corticosteroids has been associated with a dose-related increased risk of
fracture. This may be related to systemic absorption. However, several studies have found …

Background It is uncertain whether long-term use of inhaled corticosteroids (ICSs), widely
used to treat COPD, increases the risk of fracture, particularly in women, in view of the …

The effect of inhaled corticosteroids (ICS) on the risk of osteoporosis and fracture in patients
with chronic obstructive pulmonary disease (COPD) remains uncertain. The aim of this study …

BACKGROUND: There are disputes whether inhaled corticosteroids (ICS) increase the
incidence of fracture or osteoporosis among patients with COPD. The aim of this meta …